The UK just became the latest country to offer a pill version of semaglutide for weight management. On 6 July 2026, Novo Nordisk’s Wegovy tablet became available for private purchase in high street and online pharmacies across Britain - and the demand has been immediate.
Boots launched the daily tablet from £79 per month, with some online providers offering the first month from as low as £60 as they compete for market share. According to reporting by Metro and Yahoo News UK, roughly 70,000 people had already signed up before the tablet was even available.
What Exactly Is the Wegovy Tablet?
The Wegovy tablet contains oral semaglutide - the same active ingredient as the injectable Wegovy pen, but formulated as a once-daily pill. It is not the same as Eli Lilly’s orforglipron (brand name Foundayo), which we covered in a previous post. Orforglipron is a small-molecule GLP-1 agonist. Wegovy’s tablet is a peptide-based formulation with a penetration enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate) that helps semaglutide survive the stomach environment.
The key difference: Wegovy tablets require taking it on an empty stomach with a small amount of water and waiting 30 minutes before eating. Orforglipron can be taken with food. From a real-world adherence standpoint, that 30-minute window matters.
What the Research Says
The Wegovy tablet’s approval in the UK was based on data from Novo Nordisk’s OASIS clinical trial programme. The OASIS 1 trial reported that oral semaglutide 50mg achieved approximately 15% average body weight loss over 68 weeks in adults with obesity or overweight with at least one comorbidity.
That number sits between semaglutide injection (typically 15-17% in STEP trials) and tirzepatide/Mounjaro injection (up to 22.5%). The tablet is less potent than the injection at comparable doses, but it removes the needles - and for many people, that’s the deciding factor.
The BMJ noted in their analysis published this week that while the tablet offers more convenience, it may not be the “game-changer” some expect. The UK’s MHRA approved it for private sale only - NHS access is likely years away given the cost implications of scaling oral semaglutide across a public health system.
The Fake Pill Problem
Here’s the part that matters most for this community. Within hours of the UK launch, Medindia reported that the majority of UK pharmacists surveyed expect counterfeit Wegovy tablets to flood the illegal market. It’s a pattern we’ve already seen with injectable semaglutide and tirzepatide globally.
The oral format makes this even more concerning. Tablets are easier to manufacture, easier to ship, and easier to disguise than injectable pens. A fake Wegovy tablet could contain anything - underdosed active ingredient, wrong compound, or nothing at all.
For Australian researchers watching this space, the takeaway is clear. The availability of legitimate oral GLP-1 formulations is expanding globally, but so is the counterfeit market around them.
What This Means for Australia
There is no oral semaglutide product currently registered with the TGA for weight management in Australia. The TGA approved injectable Wegovy (semaglutide 2.4mg) for chronic weight management in 2022, but the oral formulation has not followed.
Australia’s regulatory pathway for oral GLP-1 drugs will likely depend on both Novo Nordisk’s commercial strategy and TGA’s assessment timeline. Given that the UK MHRA approved the tablet in June 2026 and it launched for sale on July 6, Australia could be 12-18 months behind if Novo submits a registration application.
In the meantime, the oral GLP-1 landscape continues to expand internationally. Foundayo (orforglipron) was approved by the FDA in April 2026, and AstraZeneca’s elecoglipron entered Phase 3 trials following positive mid-stage results. The direction of travel is clear - injectable GLP-1s are not the endgame.
Sources
Source: BMJ - Wegovy weight loss pill now available to UK patients - published July 7, 2026 Source: Forbes - Wegovy Weight Loss Pills: How To Get Semaglutide GLP-1 Tablets In The UK - published July 9, 2026 Source: Daily Express - Full list of people not allowed to buy Wegovy weight loss pills - published July 9, 2026 Source: Medindia - Could Fake Wegovy Pills Rise as UK Pharmacies Launch the Tablets? - published July 8, 2026 Source: Yahoo News UK - Wegovy weight loss pill hits UK high streets - published July 7, 2026
This article is for educational and informational purposes only. It does not constitute medical advice, therapeutic recommendations, or endorsements of any compound. Grey Highway is a research-education community. We do not sell, supply, or promote the use of research compounds. Always consult a qualified healthcare professional regarding health decisions. For Australian regulatory information, visit the TGA website.